The Company Catalyst Biosciences Inc. (United States), is listed on Nasdaq with a market value of $ 239.53 Millions, having an equity of $ 116.64 Millions.
With a total of 56 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.
In the last 12 months the Company had a revenue of $ -, which generated a loss in the amount of $ -64.27 Millions.
As for its main indicators, the Company has a P/E ratio of -3.73, a P/BV ratio of 2.05 and in the last 12 months the Company did not pay dividends.
The Company is traded internationally through the ticker CBIO.